The author of the article comments that he doesn't
Post# of 153897
(Total Views: 362)
Posted On: 09/05/2019 6:38:46 PM
The author of the article comments that he doesn't have
an opinion on Cytodyn because he hasn't followed it. It's an illuminating comment for a guy who runs a biotech stock website. It's easy to forget how far off the radar of even sector experts micro-cap biotechs that trade OTC are and bodes well for the SP when we do eventually make a splash that lasts.
Also the HC Wainwright guy has been the only analyst listed with an opinion on CYDY at Etrade for the 10 months or so I've been seriously following the stock so it's not like we have stirred up interest with those professionals yet either.
an opinion on Cytodyn because he hasn't followed it. It's an illuminating comment for a guy who runs a biotech stock website. It's easy to forget how far off the radar of even sector experts micro-cap biotechs that trade OTC are and bodes well for the SP when we do eventually make a splash that lasts.
Also the HC Wainwright guy has been the only analyst listed with an opinion on CYDY at Etrade for the 10 months or so I've been seriously following the stock so it's not like we have stirred up interest with those professionals yet either.
(0)
(0)